Roerden, M. & Spranger, S. Cancer immune evasion, immunoediting and intratumour heterogeneity. Nat. Rev. Immunol. 25, 353–369 (2025).

Article  PubMed  CAS  Google Scholar 

Mao, X. et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol. Cancer 20, 131 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cheng, K. et al. Tumor-associated macrophages in liver cancer: from mechanisms to therapy. Cancer Commun. 42, 1112–1140 (2022).

Article  Google Scholar 

Propper, D. J. & Balkwill, F. R. Harnessing cytokines and chemokines for cancer therapy. Nat. Rev. Clin. Oncol. 19, 237–253 (2022).

Article  PubMed  CAS  Google Scholar 

Ozga, A. J., Chow, M. T. & Luster, A. D. Chemokines and the immune response to cancer. Immunity 54, 859–874 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bergers, G. & Benjamin, L. E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, 401–410 (2003).

Article  PubMed  CAS  Google Scholar 

Fan, Y. Vascular detransformation for cancer therapy. Trends Cancer 5, 460–463 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huinen, Z. R., Huijbers, E. J. M., van Beijnum, J. R., Nowak-Sliwinska, P. & Griffioen, A. W. Anti-angiogenic agents—overcoming tumour endothelial cell anergy and improving immunotherapy outcomes. Nat. Rev. Clin. Oncol. 18, 527–540 (2021).

Article  PubMed  Google Scholar 

Ma, W. et al. Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma. Nat. Cancer 2, 83–97 (2021).

Article  PubMed  CAS  Google Scholar 

Huang, M. et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J. Clin. Invest. 126, 1801–1814 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Liu, T. et al. PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma. Nat. Commun. 9, 3439 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Huijbers, E. J. M., Khan, K. A., Kerbel, R. S. & Griffioen, A. W. Tumors resurrect an embryonic vascular program to escape immunity. Sci. Immunol. 7, eabm6388 (2022).

Article  PubMed  CAS  Google Scholar 

Wang, Q. et al. Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α. Nat. Commun. 9, 559 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Mulligan, J. K. & Young, M. R. Tumors induce the formation of suppressor endothelial cells in vivo. Cancer Immunol. Immunother. 59, 267–277 (2010).

Article  PubMed  CAS  Google Scholar 

Folkman, J. Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug. Discov. 6, 273–286 (2007).

Article  PubMed  CAS  Google Scholar 

Carmeliet, P. Angiogenesis in life, disease and medicine. Nature 438, 932–936 (2005).

Article  PubMed  CAS  Google Scholar 

Huang, Y. et al. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc. Natl Acad. Sci. USA 109, 17561–17566 (2012).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dong, X. et al. Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice. J. Immunother. Cancer 11, e005583 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Chae, S. S. et al. Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. Clin. Cancer Res. 16, 3618–3627 (2010).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Park, J. S. et al. Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment. Cancer Cell 30, 953–967 (2016).

Article  PubMed  CAS  Google Scholar 

Kim, J. et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J. Clin. Invest. 127, 3441–3461 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Datta, M. et al. Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models. Proc. Natl Acad. Sci. USA 120, e2219199120 (2023).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Maes, H. et al. Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell 26, 190–206 (2014).

Article  PubMed  CAS  Google Scholar 

Lu, Z. et al. Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies. Sci. Transl. Med. 16, eadn0904 (2024).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cleveland, A. H. & Fan, Y. Reprogramming endothelial cells to empower cancer immunotherapy. Trends Mol. Med. 30, 126–135 (2024).

Article  PubMed  CAS  Google Scholar 

De Bock, K. et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154, 651–663 (2013).

Article  PubMed  Google Scholar 

Cantelmo, A. R. et al. Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy. Cancer Cell 30, 968–985 (2016).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shan, Y. et al. Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment. Acta Pharm. Sin. B 12, 1825–1839 (2022).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang, D. et al. PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy. Cell Metab. 35, 517–534.e8 (2023).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schoors, S. et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520, 192–197 (2015).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Milutinovic, S., Abe, J., Godkin, A., Stein, J. V. & Gallimore, A. The dual role of high endothelial venules in cancer progression versus immunity. Trends Cancer 7, 214–225 (2021).

Article  PubMed  PubMed Central  CAS